These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 25740944)

  • 1. Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.
    Blidner AG; Salatino M; Mascanfroni ID; Diament MJ; Bal de Kier Joffé E; Jasnis MA; Klein SM; Rabinovich GA
    J Immunol; 2015 Apr; 194(7):3452-62. PubMed ID: 25740944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mn complex-mediated enhancement of antitumor response through modulating myeloid-derived suppressor cells in drug-resistant tumor.
    Das S; Banerjee K; Roy S; Majumder S; Chatterjee M; Majumdar S; Choudhuri SK
    In Vivo; 2014; 28(5):909-18. PubMed ID: 25189907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts.
    Maenhout SK; Van Lint S; Emeagi PU; Thielemans K; Aerts JL
    Int J Cancer; 2014 Mar; 134(5):1077-90. PubMed ID: 23983191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
    Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
    J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.
    Younos I; Donkor M; Hoke T; Dafferner A; Samson H; Westphal S; Talmadge J
    Int Immunopharmacol; 2011 Jul; 11(7):816-26. PubMed ID: 21376153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
    Parker KH; Beury DW; Ostrand-Rosenberg S
    Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
    Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
    Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma.
    Sevko A; Sade-Feldman M; Kanterman J; Michels T; Falk CS; Umansky L; Ramacher M; Kato M; Schadendorf D; Baniyash M; Umansky V
    J Invest Dermatol; 2013 Jun; 133(6):1610-9. PubMed ID: 23223128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation.
    Lee JM; Kim EK; Seo H; Jeon I; Chae MJ; Park YJ; Song B; Kim YS; Kim YJ; Ko HJ; Kang CY
    Eur J Immunol; 2014 Jun; 44(6):1672-84. PubMed ID: 24659444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
    Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
    Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.
    Haile LA; Gamrekelashvili J; Manns MP; Korangy F; Greten TF
    J Immunol; 2010 Jul; 185(1):203-10. PubMed ID: 20525890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baccatin III, a precursor for the semisynthesis of paclitaxel, inhibits the accumulation and suppressive activity of myeloid-derived suppressor cells in tumor-bearing mice.
    Lee YH; Lee YR; Park CS; Im SA; Song S; Hong JT; Whang BY; Kim K; Lee CK
    Int Immunopharmacol; 2014 Aug; 21(2):487-93. PubMed ID: 24957690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cell function is diminished in aspirin-triggered allergic airway hyperresponsiveness in mice.
    Shi M; Shi G; Tang J; Kong D; Bao Y; Xiao B; Zuo C; Wang T; Wang Q; Shen Y; Wang H; Funk CD; Zhou J; Yu Y
    J Allergy Clin Immunol; 2014 Nov; 134(5):1163-74.e16. PubMed ID: 24948368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
    Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
    Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide.
    Liao J; Wang X; Bi Y; Shen B; Shao K; Yang H; Lu Y; Zhang Z; Chen X; Liu H; Wang J; Chu Y; Xue L; Wang X; Liu G
    J Leukoc Biol; 2014 Nov; 96(5):675-84. PubMed ID: 24948701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
    Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
    Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer.
    Forghani P; Waller EK
    Breast Cancer Res Treat; 2015 Aug; 153(1):21-30. PubMed ID: 26208484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases.
    Kwak Y; Kim HE; Park SG
    Arch Immunol Ther Exp (Warsz); 2015 Aug; 63(4):269-85. PubMed ID: 25990434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.